Related Experiment Videos
Active site-directed thrombin inhibitors--II. Studies related to arginine/guanidine bioisosteres
D R St Laurent1, N Balasubramanian, W T Han
1Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492-7660, USA.
Bioorganic & Medicinal Chemistry
|August 1, 1995
Abstract:
A series of N-arylsulfonylarginine amides was synthesized wherein the guanidine or arginine moiety was isosterically replaced by a number of heterocyclic functionalities. These compounds were evaluated as potential active-site inhibitors of thrombin. Bisamidines 11a-n showed a similar SAR to that of simple arginine compounds. The ex vivo clotting time measurement of 11d after ip dosing showed prolongation of clotting time in rats.